close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Why ImmunityBio Stock Is Down More Than 20% Today ↗
Via The Motley Fool
Tickers IBRX
Exposures Product Safety
News headline image
ImmunityBio Crashes On FDA Warning Over Anktiva Claims ↗
Via Benzinga
Tickers IBRX
Exposures Product Safety
News headline image
Food and Drug Administration Adds AAMI Cybersecurity Guidance to Recognized Consensus Standards Database
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
News headline image
Ford Recalls 254,000 SUVs Over Software Issues Affecting Driver Assistance Features ↗
Via Benzinga
Topics Product Recall
Tickers F
Exposures Legal Product Safety
News headline image
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
Via MarketMinute
Topics ETFs Earnings
Tickers AMGN LLY NVO
Exposures Financial Product Safety
News headline image
Accepted into Advanced Micro Devices ($AMD) AI Developer Program to Accelerate LLM Training and Inference : Avalon GloboCare Corp. (Nasdaq: ALBT)
Via Get News
Topics Artificial Intelligence Intellectual Property
Tickers ALBT AMD
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Cairdio Emerges as Healthcare Clinical Guardian Following Successful Showcase at Lone Star HealthTech AI Summit 2026
Via Press Advantage
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers AMRN BHVN CYTK INVA IRWD NBIX
Exposures Legal Product Safety Regulatory
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed; April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed; April 13, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
Via MarketMinute
Tickers ABBV AMGN BMY JNJ PTGX
Exposures Product Safety
News headline image
Envoy Medical Reports Full Year 2025 Financial Results
Via Newsfile
Topics Intellectual Property
Tickers ASX:COH COCH
Exposures Intellectual Property Product Safety
News headline image
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Via StockStory
Tickers DXCM HIMS NVAX
Exposures COVID-19 Product Safety
News headline image
uniQure N.V. (QURE) Class Action Lawsuit: Investors Face April 13, 2026, Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
uniQure N.V. (QURE) Class Action Lawsuit: Investors Face April 13, 2026, Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? ↗
Via The Motley Fool
Topics Intellectual Property
Tickers LLY MMM NVO VKTX
Exposures Intellectual Property Product Safety
News headline image
NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE)
Via NewMediaWire
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
NASDAQ: QURE: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE)
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers QURE
Exposures Financial Legal Product Safety
News headline image
Should Tesla Be Worried About the National Highway Traffic Safety Administration? (Yes.) ↗
Via The Motley Fool
Topics Death Product Recall
Tickers TSLA
Exposures Death Legal Product Safety
A Small Danish Factory Maker Found a Way to Survive Globalization. The Answer Was to Go Global.
Via Visibility
Topics Product Recall Supply Chain
Exposures Legal Product Safety Supply Chain
News headline image
From Early Trading Losses to Global Impact: Somesh’s Journey to Building an International Trading Community
Via Get News
Topics Product Recall
Exposures Legal Product Safety
News headline image
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year ↗
Via The Motley Fool
Tickers CYTK INSM REGN RVMD VERA
Exposures Lead Product Safety
News headline image
Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma ↗
Via Benzinga
Exposures Product Safety
News headline image
Moment of Clarity Publishes Comprehensive New Resource on Website Discussing Steps in Spravato Treatment for Recovery
Via Press Advantage
Exposures Product Safety
News headline image
Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026
Via Finterra
Topics Intellectual Property
Tickers BLK BLUE CRSP GS JPM RDDT
Exposures Intellectual Property Product Safety
News headline image
Rhythm Pharma Wins FDA Approval For First-Ever Rare Weight Disorder Therapy ↗
Via Benzinga
Exposures Product Safety
MissionIRNewsBreaks – Black Hawk Acquisition Corporation (Nasdaq: BKHA) SPAC Target Vesicor Therapeutics Names Michael Tolentino CEO
Via Investor Brand Network
Tickers BKHA
Exposures Product Safety
News headline image
Rhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat' ↗
Via Investor's Business Daily
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today